Showing results (41-50 of 105) with videos related to
Sort By:
Pageof 11
Diabetes, Obesity & Metabolism|February 24, 2018
Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV studyShin-Ichi Harashima, Nobuya Inagaki, Kazuoki Kondo, et al.Psychiatry and Clinical Neurosciences|September 17, 2022
Efficacy and safety of valbenazine in Japanese patients with tardive dyskinesia: A multicenter, randomized, double-blind, placebo-controlled study (J-KINECT)Jun Horiguchi, Koichiro Watanabe, Kazuoki Kondo, et al.Pharmacology, Biochemistry, and Behavior|August 13, 2019
Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor T-251 in rodentsMisae Takakuwa, Yumi Watanabe, Kiichi Tanaka, et al.Journal of Bone and Mineral Metabolism|August 18, 2019
Low serum 25-hydroxyvitamin D is associated with low grip strength in an older Japanese populationTaeko Kitsu, Keiko Kabasawa, Yumi Ito, et al.Marine Genomics|December 5, 2018
Development of endogenous promoters that drive high-level expression of introduced genes in the model diatom Phaeodactylum tricornutumYumi Watanabe, Takashi Kadono, Nozomu Kira, et al.Journal of Pharmacological Sciences|January 12, 2008
Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptorYumi Watanabe, Hidetoshi Asai, Taketoshi Ishii, et al.Genes & Development|April 14, 2004
Conversion of myoblasts to physiologically active neuronal phenotypeYumi Watanabe, Sei Kameoka, Vidya Gopalakrishnan, et al.Dementia and Geriatric Cognitive Disorders Extra|October 21, 2020
Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's DiseaseYumi Watanabe, Yoshitoshi Hirao, Kensaku Kasuga, et al.Fukushima Journal of Medical Science|November 8, 2021
Secular changes in bone mineral density of adult Japanese women from 1995 to 2013Hiroaki Watanabe, Yasuko Minagawa, Ichiro Suzuki, et al.Pharmacology, Biochemistry, and Behavior|June 21, 2020
Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor MT-3014 in ratsMisae Takakuwa, Yumi Watanabe, Takeaki Saijo, et al.Pageof 11